Skip to search.
 TSX Down 0.87% TSX Ventures Down 0.21%

Neuralstem, Inc. (CUR)

-NasdaqCM
1.46 Down 0.06(3.95%) Sep 4, 4:00PM EDT
Add to Portfolio
Prev Close:1.52
Open:1.50
Bid:1.40 x 300
Ask:1.60 x 500
1y Target Est:8.00
Beta:3.13358
Earnings Date:Nov 5 - Nov 9 (Est.)
Day's Range:1.46 - 1.53
52wk Range:1.25 - 3.92
Volume:201,728
Avg Vol (3m):623,823
Market Cap:134.01M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CURDown 3.95%134.01M
STEMUp 3.65%58.49M
GERNDown 3.48%526.61M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9,249.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.26
Quarterly EPS Est (Sep-15) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and small molecule compounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback